Remove 2015 Remove Cultivation Remove Epilepsy Remove State Laws
article thumbnail

Will Georgia Legalize Cannabis? GA Medical Cannabis Program Explained

Veriheal

Though Georgia is one of the last states to officially legalize medical cannabis, the state has been gradually reforming its laws around low-THC cannabis oil for qualifying patients. In 2015, Georgia passed HB 1, also known as the Haleigh’s Hope Act, allowing medical cannabis oil for medical use.

article thumbnail

MMJ Laws In Texas: Your Complete Guide

MMJ Recs

The Texas Compassionate Use Program (TCUP) represents the Lone Star State’s cautious foray into the realm of medical marijuana. Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals.

Law 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Status of Cannabis Legalization in the South

Cannabis Law Report

The law created the Alabama Medical Cannabis Commission (AMCC) , which is generally responsible for regulating the medical cannabis program, including licensing facilities that process, transport, test, or dispense medical cannabis. Until 2019, however, no law provided a way to access that oil.

article thumbnail

Georgia medical cannabis program starts

Cannabis Law Report

The appointments were a key step for patients who have been allowed to use the drug since 2015 but had no legal way to buy, grow or transport it. State law allows marijuana oil to treat severe seizures, terminal cancers, Parkinson’s disease and other illnesses. He said he hopes the commission moves quickly.

article thumbnail

Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s

Cannabis Law Report

While this is a positive step and will provide a new treatment option for those with two types of intractable epilepsy, it is my understanding that this scheduling action relates only to CBD in an FDA-approved formulation. The first letter was sent on May 13, 2015, and the second letter was sent on November 18, 2018.

article thumbnail

Can medical cannabis survive adult-use legalization?

The Cannigma

But I imagine, it’s all connected that it also has an effect on like a product development and even cultivation and R&D perspective, if there’s less of a market, if there’s more money to be made on the recreational side, that these products are also not being developed as much, which is probably the biggest shame.